Table 2. Characteristics of the participants.
| Characteristics | Value |
|---|---|
| Age, median (IQR) | 72.5 (67.5–79.5) |
| Marital Status, n [%] | |
| Married | 20 [71] |
| Single | 1 [4] |
| Divorced | 3 [11] |
| Widowed | 4 [14] |
| Education, n [%] | |
| Middle school or below | 9 [32] |
| High school | 9 [32] |
| College or above | 10 [36] |
| AJCC Stage, n [%] | |
| I | 2 [7] |
| II | 11 [39] |
| III | 7 [25] |
| IV | 8 [29] |
| Grade Group, n [%] | |
| GG1 | 5 [18] |
| GG2 | 4 [14] |
| GG3 | 6 [21] |
| GG4 | 8 [29] |
| GG5 | 5 [18] |
| PSA level (ng/mL) at diagnosis, median (IQR) | 40.7 (16.9-103.8) |
| Current treatment, n [%] | |
| Prostatectomy | 11 [39] |
| Radiation | 5 [18] |
| Androgen deprivation therapy | 10 [36] |
| Active surveillance | 2 [7] |
| Comorbidity, n [%] | |
| Yes | 24 [86] |
| No | 4 [14] |
IQR, interquartile range; AJCC Stage, American Joint Committee on Cancer (AJCC) TNM Staging System For Prostate Cancer (8th ed., 2017); Grade Group, The 2014 International Society of Urological Pathology Modified Gleason Grading System; PSA, prostate-specific antigen.